کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
10914853 | 1088821 | 2014 | 13 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
تحقیقات سرطان
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer](/preview/png/10914853.png)
چکیده انگلیسی
FEN1 has key roles in Okazaki fragment maturation during replication, long patch base excision repair, rescue of stalled replication forks, maintenance of telomere stability and apoptosis. FEN1 may be dysregulated in breast and ovarian cancers and have clinicopathological significance in patients. We comprehensively investigated FEN1 mRNA expression in multiple cohorts of breast cancer [training set (128), test set (249), external validation (1952)]. FEN1 protein expression was evaluated in 568 oestrogen receptor (ER) negative breast cancers, 894 ER positive breast cancers and 156 ovarian epithelial cancers. FEN1 mRNA overexpression was highly significantly associated with high grade (p = 4.89 Ã 10â57), high mitotic index (p = 5.25 Ã 10â28), pleomorphism (p = 6.31 Ã 10â19), ER negative (p = 9.02 Ã 10â35), PR negative (p = 9.24 Ã 10â24), triple negative phenotype (p = 6.67 Ã 10â21), PAM50.Her2 (p = 5.19 Ã 10â13), PAM50. Basal (p = 2.7 Ã 10â41), PAM50.LumB (p = 1.56 Ã 10â26), integrative molecular cluster 1 (intClust.1) (p = 7.47 Ã 10â12), intClust.5 (p = 4.05 Ã 10â12) and intClust. 10 (p = 7.59 Ã 10â38) breast cancers. FEN1 mRNA overexpression is associated with poor breast cancer specific survival in univariate (p = 4.4 Ã 10â16) and multivariate analysis (p = 9.19 Ã 10â7). At the protein level, in ER positive tumours, FEN1 overexpression remains significantly linked to high grade, high mitotic index and pleomorphism (ps < 0.01). In ER negative tumours, high FEN1 is significantly associated with pleomorphism, tumour type, lymphovascular invasion, triple negative phenotype, EGFR and HER2 expression (ps < 0.05). In ER positive as well as in ER negative tumours, FEN1 protein overexpression is associated with poor survival in univariate and multivariate analysis (ps < 0.01). In ovarian epithelial cancers, similarly, FEN1 overexpression is associated with high grade, high stage and poor survival (ps < 0.05). We conclude that FEN1 is a promising biomarker in breast and ovarian epithelial cancer.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Molecular Oncology - Volume 8, Issue 7, October 2014, Pages 1326-1338
Journal: Molecular Oncology - Volume 8, Issue 7, October 2014, Pages 1326-1338
نویسندگان
Tarek M.A. Abdel-Fatah, Roslin Russell, Nada Albarakati, David J. Maloney, Dorjbal Dorjsuren, Oscar M. Rueda, Paul Moseley, Vivek Mohan, Hongmao Sun, Rachel Abbotts, Abhik Mukherjee, Devika Agarwal, Jennifer L. Illuzzi, Ajit Jadhav, Anton Simeonov,